Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Cypress Bioscience to develop Pierre Fabre's milnacipran for chronic pain syndromes

Aug. 2, 2001

Results presented for rotigotine transdermal in early and advanced PD

Aug. 2, 2001

Major tea polyphenol attenuates neuronal cell death in vivo

Aug. 2, 2001

New derivatives for reversing drug-induced neuromuscular block presented by Azko Nobel

Aug. 1, 2001

Compounds with neurotrophic and neuroprotective activity disclosed by Bristol-Myers Squibb

Aug. 1, 2001

Novartis's TCH-346 is neuroprotective against MPTP toxicity in monkeys

Aug. 1, 2001

GPI-1046 protects nigral neurons in mice

Aug. 1, 2001

Amarin and Elan announce partnership to establish Parkinson's franchise

Aug. 1, 2001

Opioid receptor ligands designed by Euroceltique particularly useful as analgesics

July 31, 2001

ICPD news: JP-1730 as a novel therapeutic approach to dyskinesias

July 31, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...